Hepatic microfluidic bioreactor

Knowledge Source Identification
Knowledge source name Hepatic microfluidic bioreactor
Abbreviated name HeMiBio
Owner/Developer European Commission and Cosmetics Europe
Country Belgium
Languages English
URL http://www.hemibio.eu/
Contact http://www.hemibio.eu/contact-us
Description The goal of HeMiBio is to develop a hepatic microfluidic bioreactor from human iPSC-derived hepatocytes, hepatic sinusoidal endothelial cells (HSEC) and stellate cells (HSC), suitable for inclusion in a repeated dose toxicity testing strategy of pharmaceuticals/cosmetic ingredients.
Knowledge Source Category
Category Research Program/Project/Grant
Sub categories EU Program
Knowledge Dissemination and Sharing
Dissemination channel Face-to-face, Website, Printed
Targeted audience (specified/objective analysis) Scientists, Regulators, Industry, Researchers
Users access Open access
Knowledge Characterization
3Rs relevance Replacement
Purpose Regulatory testing, Fundamental studies, Toxicological and safety evaluation, Method development
Technology/Tools Stem cells, Tissue engineering, Alternative test methods (in vitro)